Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression

BACKGROUND: Sp1, an important transcription factor, is involved in the progression of various cancers. Our previous studies have indicated that Sp1 levels are increased in the early stage of lung cancer progression but decrease during the late stage, leading to poor prognosis. In addition, estrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Ming-Jer, Chen, Yung-Ching, Wang, Shao-An, Chang, Hui-Ping, Yang, Wen-Bin, Lee, Chia-Chi, Liu, Chia-Yu, Tseng, Yau-Lin, Wang, Yi-Ching, Sun, H. Sunny, Chang, Wen-Chang, Hung, Jan-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762881/
https://www.ncbi.nlm.nih.gov/pubmed/35034634
http://dx.doi.org/10.1186/s12929-022-00787-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762881/
https://www.ncbi.nlm.nih.gov/pubmed/35034634
http://dx.doi.org/10.1186/s12929-022-00787-1

Ejemplares similares